News
OPHLF
14.55
NaN%
--
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
TipRanks · 06/05 16:31
Analysts Are Neutral on These Healthcare Stocks: CSL (CMXHF), ONO Pharmaceutical Co (OPHLF)
TipRanks · 05/31 12:20
ONO’s ONO-7018 Trial Termination: What It Means for OPHLF Investors
TipRanks · 05/29 16:31
Ono’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF
TipRanks · 05/20 16:30
Ono’s Phase 3 Sapablursen Trial Targets Polycythemia Vera Upside for OPHLF Investors
TipRanks · 05/08 16:34
Ono Pharmaceutical reports FY results
Seeking Alpha · 05/08 09:55
ONO Pharmaceutical Details FY2025 Results and FY2026 Outlook with Focus on Pipeline and Core Metrics
TipRanks · 05/08 03:22
Ono Pharmaceutical Delivers Strong FY 2025 Profits but Guides for Lower Revenue in FY 2026
TipRanks · 05/08 03:22
Inhibrx cancer drug reportedly drawing interest of Merck and rivals
Seeking Alpha · 04/22 12:37
Goldman Sachs Remains a Sell on ONO Pharmaceutical Co (OPHLF)
TipRanks · 04/15 11:59
Ono Pharma Submits Application For Manufacturing And Marketing Approval Of Ripretinib
NASDAQ · 03/26 06:32
ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso
TipRanks · 03/13 16:30
Pfizer wins full FDA approval for Braftovi in colorectal cancer
Seeking Alpha · 02/24 18:26
Pfizer says cancer therapy Braftovi improved survival in late-stage trial
Seeking Alpha · 02/17 14:11
Ono Pharmaceutical GAAP EPS of ¥146.07, revenue of ¥397.04B; reaffirms FY outlook
Seeking Alpha · 02/02 06:11
Ono Pharmaceutical Co. Ltd. Reveals Climb In Nine Months Bottom Line
NASDAQ · 02/02 05:04
ONO Pharmaceutical Posts Strong Profit Growth in Q3 FY2025 and Maintains Full-Year Outlook
TipRanks · 02/02 03:22
Ono Pharma Taiwan Receives Additional Approval Of Opdivo In Combination With Ipilimumab
NASDAQ · 01/14 07:12
Ono Pharmaceutical reports Q2 results
Seeking Alpha · 10/30/2025 12:52
ONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
TipRanks · 10/30/2025 03:22
More
Webull provides a variety of real-time OPHLF stock news. You can receive the latest news about Ono Pharmaceutic through multiple platforms. This information may help you make smarter investment decisions.
About OPHLF
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.